MetaADEDB 2.0 @ LMMD
Metformin
(XZWYZXLIPXDOLR-UHFFFAOYSA-N)
Structure
SMILES
CN(C(=N)N=C(N)N)C
Type(s)
Approved
ATC code(s)
A10BA02; A10BD02; A10BD03; A10BD05; A10BD07; A10BD08; A10BD10; A10BD11; A10BD13; A10BD14; A10BD15; A10BD16; A10BD17; A10BD18; A10BD20; A10BD22; A10BD23; A10BD25
Molecular Formula:
C4H11N5
Molecular Weight:
129.164
Log P:
0.2565
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
3
TPSA:
91.49
CAS Number(s):
657-24-9; 1115-70-4
Synonym(s)
1.
Metformin
2.
Dimethylguanylguanidine
3.
Dimethylbiguanidine
4.
Glucophage
5.
Metformin HCl
6.
Metformin Hydrochloride
7.
HCl, Metformin
8.
Hydrochloride, Metformin
External Link(s)
MeSHD008687
PubChem Compound4091
BindingDB50229665
57047
ChEBI6801
CHEMBLCHEMBL1431
DrugBankDB00331
DrugCentral1725
IUPHAR/BPS Guide to PHARMACOLOGY4503
4779
KEGGcpd:C07151
dr:D04966
Therapeutic Target DatabaseD09AYI
D0D7LA
ZINC12859773
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Acute kidney injuryFAERS: 799
Canada Vigilance: 7

View details

CTD
Canada Vigilance
US FAERS
2Toxicity to various agentsFAERS: 596
Canada Vigilance: 14
Canada Vigilance
US FAERS
3Metabolic acidosisFAERS: 517
Canada Vigilance: 6
Canada Vigilance
OFFSIDES
US FAERS
4VomitingFAERS: 350
Canada Vigilance: 13
14604317
14984458
CTD
SIDER
Canada Vigilance
US FAERS
5HypotensionFAERS: 3149152364
14604317
CTD
SIDER
US FAERS
6Blood glucose increasedFAERS: 302
Canada Vigilance: 26
Canada Vigilance
US FAERS
7NauseaFAERS: 275
Canada Vigilance: 49
14984458
15752411
CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
8Drug ineffectiveFAERS: 238
Canada Vigilance: 42
Canada Vigilance
US FAERS
9Blood creatinine increasedFAERS: 211
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
10Suicide attemptFAERS: 173US FAERS
11MalaiseFAERS: 170
Canada Vigilance: 10
Canada Vigilance
SIDER
US FAERS
12ShockFAERS: 164
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
13Drug level increasedFAERS: 160
Canada Vigilance: 4
Canada Vigilance
US FAERS
14Abdominal PainFAERS: 142
Canada Vigilance: 25
15752411CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
15OverdoseFAERS: 141
Canada Vigilance: 7
Canada Vigilance
US FAERS
16Cardiac ArrestFAERS: 133
Canada Vigilance: 3
Canada Vigilance
US FAERS
17Abdominal discomfortFAERS: 130
Canada Vigilance: 28
Canada Vigilance
OFFSIDES
SIDER
US FAERS
18Completed SuicideFAERS: 127US FAERS
19DehydrationFAERS: 117
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
20AnuriaFAERS: 11115752411CTD
US FAERS
21FatigueFAERS: 101
Canada Vigilance: 5
10644400CTD
SIDER
Canada Vigilance
US FAERS
22AstheniaFAERS: 95
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
SIDER
US FAERS
23Respiratory FailureFAERS: 84
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
24Product substitution issueFAERS: 82
Canada Vigilance: 26
Canada Vigilance
US FAERS
25DizzinessFAERS: 79
Canada Vigilance: 15
Canada Vigilance
SIDER
US FAERS
26Blood pH decreasedFAERS: 77
Canada Vigilance: 2
Canada Vigilance
US FAERS
27HeadacheFAERS: 75
Canada Vigilance: 18
Canada Vigilance
SIDER
US FAERS
28Weight decreasedFAERS: 74
Canada Vigilance: 2
Canada Vigilance
US FAERS
29Diabetes mellitus inadequate controlFAERS: 66
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
30Blood glucose decreasedFAERS: 64OFFSIDES
US FAERS
31Myocardial InfarctionFAERS: 6318484962
24842192
CTD
US FAERS
32Creatinine renal clearance decreasedFAERS: 61US FAERS
33HypocapniaFAERS: 60US FAERS
34PCO2 decreasedFAERS: 60US FAERS
35TachycardiaFAERS: 57
Canada Vigilance: 1
9152364CTD
Canada Vigilance
US FAERS
36Base excess decreasedFAERS: 56US FAERS
37Blood potassium increasedFAERS: 55OFFSIDES
US FAERS
38HypersensitivityFAERS: 55
Canada Vigilance: 2
Canada Vigilance
US FAERS
39SomnolenceFAERS: 55
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
40Product quality issueFAERS: 54
Canada Vigilance: 2
Canada Vigilance
US FAERS
41SepsisFAERS: 54
Canada Vigilance: 1
Canada Vigilance
US FAERS
42AgitationFAERS: 52US FAERS
43Depressed Level of ConsciousnessFAERS: 52US FAERS
44Blood chloride decreasedFAERS: 48US FAERS
45Blood sodium decreasedFAERS: 46US FAERS
46Drug abuseFAERS: 45US FAERS
47PainFAERS: 45
Canada Vigilance: 1
Canada Vigilance
US FAERS
48LethargyFAERS: 42
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
49FlatulenceFAERS: 40
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
50Medication residue presentFAERS: 40US FAERS
51Blood phosphorus increasedFAERS: 39US FAERS
52KetoacidosisFAERS: 38SIDER
US FAERS
53Mental status changesFAERS: 37US FAERS
54Blood urea increasedFAERS: 36US FAERS
55Unresponsive to stimuliFAERS: 36
Canada Vigilance: 6
Canada Vigilance
US FAERS
56PneumoniaFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
57Blood glucose abnormalFAERS: 34
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
58SoporFAERS: 34US FAERS
59AlopeciaFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
60Medication ErrorFAERS: 33US FAERS
61AcidosisFAERS: 32OFFSIDES
SIDER
US FAERS
62Back PainFAERS: 32
Canada Vigilance: 2
Canada Vigilance
US FAERS
63Chest PainFAERS: 32
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
64Feeling abnormalFAERS: 32
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
65Incorrect dose administeredFAERS: 32US FAERS
66Septic ShockFAERS: 32US FAERS
67DyspepsiaFAERS: 31
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
68Adverse eventFAERS: 30OFFSIDES
US FAERS
69PoisoningFAERS: 30
Canada Vigilance: 2
Canada Vigilance
US FAERS
70PruritusFAERS: 30
Canada Vigilance: 2
14561576CTD
SIDER
Canada Vigilance
US FAERS
71Urine albumin/creatinine ratio abnormalFAERS: 30US FAERS
72SyncopeFAERS: 29
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
73PO2 increasedFAERS: 28US FAERS
74General physical health deteriorationFAERS: 27US FAERS
75LeukocytosisFAERS: 27US FAERS
76Maternal exposure during pregnancyFAERS: 27US FAERS
77BradycardiaFAERS: 26
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
78DeliriumFAERS: 26US FAERS
79Product use in unapproved indicationFAERS: 26US FAERS
80MyalgiaFAERS: 25
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
81ConstipationFAERS: 24
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
82Diabetic metabolic decompensationFAERS: 24US FAERS
83DysenteryFAERS: 24US FAERS
84UrticariaFAERS: 24
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
85Wrong technique in product usage processFAERS: 24
Canada Vigilance: 2
Canada Vigilance
US FAERS
86ArthralgiaFAERS: 23
Canada Vigilance: 4
Canada Vigilance
US FAERS
87DisorientationFAERS: 23US FAERS
88Vasoplegia syndromeFAERS: 23US FAERS
89Diabetes MellitusFAERS: 22

View details

CTD
US FAERS
90Abdominal tendernessFAERS: 21US FAERS
91Acute myocardial infarctionFAERS: 21US FAERS
92Cerebrovascular accidentFAERS: 21US FAERS
93GastroenteritisFAERS: 21US FAERS
94PancytopeniaFAERS: 21US FAERS
95Pharmaceutical product complaintFAERS: 21US FAERS
96treatment failureFAERS: 21US FAERS
97Blood glucose fluctuationFAERS: 20
Canada Vigilance: 2
Canada Vigilance
US FAERS
98Blood magnesium increasedFAERS: 20US FAERS
99FlushingFAERS: 20
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
100RhabdomyolysisFAERS: 20OFFSIDES
US FAERS
101Systemic Inflammatory Response SyndromeFAERS: 20US FAERS
102MydriasisFAERS: 19US FAERS
103PalpitationsFAERS: 19
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
104Ventricular FibrillationFAERS: 19US FAERS
105VertigoFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
106AnhidrosisFAERS: 18US FAERS
107Blood magnesium decreasedFAERS: 18US FAERS
108Diabetic KetoacidosisFAERS: 18US FAERS
109Gastrointestinal sounds abnormalFAERS: 18US FAERS
110Drug dispensing errorFAERS: 17US FAERS
111DysgeusiaFAERS: 17SIDER
US FAERS
112ErythemaFAERS: 17
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
113Visual ImpairmentFAERS: 17US FAERS
114AnxietyFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
115HepatotoxicityFAERS: 16US FAERS
116Memory impairmentFAERS: 16
Canada Vigilance: 3
Canada Vigilance
US FAERS
117NephrolithiasisFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
118OliguriaFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
119PolyhydramniosFAERS: 16US FAERS
120Renal tubular necrosisFAERS: 16US FAERS
121Respiratory DepressionFAERS: 16US FAERS
122jaundiceFAERS: 1610644400
14561576
CTD
US FAERS
123Altered state of consciousnessFAERS: 15OFFSIDES
US FAERS
124Anion GapFAERS: 15US FAERS
125Aspartate Aminotransferase IncreasedFAERS: 15US FAERS
126Coma scale abnormalFAERS: 15US FAERS
127Acute Lung InjuryFAERS: 14US FAERS
128AortitisFAERS: 14US FAERS
129ChokingFAERS: 14US FAERS
130Deep Vein ThrombosisFAERS: 14US FAERS
131DysarthriaFAERS: 1414984458
19432690
CTD
US FAERS
132Transaminases increasedFAERS: 14US FAERS
133Unevaluable eventFAERS: 14US FAERS
134ColitisFAERS: 13US FAERS
135PO2 decreasedFAERS: 13US FAERS
136PancreatitisFAERS: 1316644670
18259965
CTD
OFFSIDES
SIDER
US FAERS
137Sinus TachycardiaFAERS: 13US FAERS
138Therapeutic response unexpected with drug substitutionFAERS: 13US FAERS
139TremorFAERS: 13
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
140Urinary tract infectionFAERS: 13US FAERS
141Alanine Aminotransferase IncreasedFAERS: 12US FAERS
142Blood phosphorus decreasedFAERS: 12US FAERS
143Disseminated Intravascular CoagulationFAERS: 12US FAERS
144EpilepsyFAERS: 12US FAERS
145Exposure via ingestionFAERS: 12US FAERS
146Peripheral swellingFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
147Product use issueFAERS: 12US FAERS
148RetchingFAERS: 12US FAERS
149AngioedemaFAERS: 11OFFSIDES
US FAERS
150Burning sensationFAERS: 11US FAERS
151ChillsFAERS: 11SIDER
US FAERS
152Distributive shockFAERS: 11US FAERS
153Drug dose omissionFAERS: 11US FAERS
154HepatitisFAERS: 119626034CTD
OFFSIDES
SIDER
US FAERS
155Hepatorenal SyndromeFAERS: 11US FAERS
156StressFAERS: 11OFFSIDES
US FAERS
157SwellingFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
158Therapy cessationFAERS: 11US FAERS
159Accidental exposure to productFAERS: 10US FAERS
160Anion gap abnormalFAERS: 10US FAERS
161CachexiaFAERS: 10US FAERS
162Cardiovascular insufficiencyFAERS: 10US FAERS
163Disease ProgressionFAERS: 10US FAERS
164DysmorphismFAERS: 10US FAERS
165Gastrointestinal PainFAERS: 10
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
166InfectionFAERS: 10SIDER
US FAERS
167PresyncopeFAERS: 10US FAERS
168Product taste abnormalFAERS: 10US FAERS
169Respiratory arrestFAERS: 10US FAERS
170Therapy non-responderFAERS: 10US FAERS
171ThrombocytopeniaFAERS: 10SIDER
US FAERS
172ArthritisFAERS: 9OFFSIDES
US FAERS
173Atrial FibrillationFAERS: 9US FAERS
174BlindnessFAERS: 920627210CTD
US FAERS
175Blood potassium decreasedFAERS: 9US FAERS
176Chest discomfortFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
177CholelithiasisFAERS: 9US FAERS
178Drug prescribing errorFAERS: 9US FAERS
179Intentional product misuseFAERS: 9US FAERS
180Live BirthFAERS: 9US FAERS
181Product physical issueFAERS: 9US FAERS
182Respiratory distressFAERS: 9SIDER
US FAERS
183Abdominal rigidityFAERS: 8US FAERS
184Accidental overdoseFAERS: 8US FAERS
185ArteriosclerosisFAERS: 8OFFSIDES
US FAERS
186CholestasisFAERS: 814561576CTD
US FAERS
187DiscomfortFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
188Drug administration errorFAERS: 8US FAERS
189Drug level above therapeuticFAERS: 8US FAERS
190Ectopic PregnancyFAERS: 8US FAERS
191Intentional drug misuseFAERS: 8US FAERS
192Irritable Bowel SyndromeFAERS: 8US FAERS
193PallorFAERS: 8US FAERS
194PregnancyFAERS: 8US FAERS
195Pulmonary EmbolismFAERS: 8US FAERS
196Skin UlcerFAERS: 8US FAERS
197AmnesiaFAERS: 7
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
198DementiaFAERS: 7US FAERS
199Diabetic NephropathyFAERS: 7OFFSIDES
US FAERS
200Feeling ColdFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
201Intentional product use issueFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
202Latent Autoimmune Diabetes in AdultsFAERS: 7US FAERS
203Lip swellingFAERS: 7US FAERS
204No adverse eventFAERS: 7US FAERS
205Ovarian adenomaFAERS: 7US FAERS
206Pulmonary HypertensionFAERS: 7US FAERS
207Therapy changeFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
208Throat irritationFAERS: 7US FAERS
209AdactylyFAERS: 6US FAERS
210AngerFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
211Angina PectorisFAERS: 6SIDER
US FAERS
212Apparent deathFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
213AtaxiaFAERS: 6US FAERS
214BronchospasmFAERS: 6US FAERS
215Cerebral disorderFAERS: 6US FAERS
216CyanosisFAERS: 6US FAERS
217EructationFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
218Gastric ulcerFAERS: 6US FAERS
219GastritisFAERS: 6US FAERS
220HyperthyroidismFAERS: 6US FAERS
221HyperventilationFAERS: 6US FAERS
222HypospadiasFAERS: 6US FAERS
223Impaired work abilityFAERS: 6
Canada Vigilance: 3
Canada Vigilance
US FAERS
224Joint swellingFAERS: 6US FAERS
225Limb discomfortFAERS: 6US FAERS
226Musculoskeletal PainFAERS: 6OFFSIDES
US FAERS
227Oropharyngeal painFAERS: 6OFFSIDES
US FAERS
228PolyneuropathyFAERS: 6US FAERS
229PolyuriaFAERS: 6US FAERS
230Prerenal failureFAERS: 6US FAERS
231Product size issueFAERS: 6US FAERS
232Product solubility abnormalFAERS: 6US FAERS
233PseudoporphyriaFAERS: 6US FAERS
234Skin lesionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
235ThrombosisFAERS: 6US FAERS
236TinnitusFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
237Activities of daily living impairedFAERS: 5US FAERS
238Blood chloride increasedFAERS: 5US FAERS
239BronchitisFAERS: 5OFFSIDES
US FAERS
240Cataract operationFAERS: 5US FAERS
241ChromaturiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
242Contraindicated product administeredFAERS: 5US FAERS
243DeafnessFAERS: 5US FAERS
244Dry skinFAERS: 5US FAERS
245EpistaxisFAERS: 5US FAERS
246HypoxiaFAERS: 5US FAERS
247Inappropriate schedule of drug administrationFAERS: 5US FAERS
248InfluenzaFAERS: 5SIDER
US FAERS
249Lichen PlanusFAERS: 5OFFSIDES
US FAERS
250Mood swingsFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
251Neck PainFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
252Oxygen consumption decreasedFAERS: 5US FAERS
253Product dispensing errorFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
254Single functional kidneyFAERS: 5US FAERS
255ThirstFAERS: 5US FAERS
256Accidental drug intake by childFAERS: 4US FAERS
257Actinic keratosisFAERS: 4US FAERS
258Acute Coronary SyndromeFAERS: 4OFFSIDES
US FAERS
259Alcohol poisoningFAERS: 4US FAERS
260Angular cheilitisFAERS: 4US FAERS
261Autoimmune hepatitisFAERS: 4US FAERS
262Blood creatine increasedFAERS: 4US FAERS
263Blood lactate dehydrogenase increasedFAERS: 4US FAERS
264BradykinesiaFAERS: 4US FAERS
265Cholestatic liver injuryFAERS: 4US FAERS
266ChoreaFAERS: 4US FAERS
267Circumstance or information capable of leading to medication errorFAERS: 4US FAERS
268CystitisFAERS: 4US FAERS
269Diabetic FootFAERS: 4OFFSIDES
US FAERS
270Diabetic foot infectionFAERS: 4US FAERS
271Drug exposure during pregnancyFAERS: 4US FAERS
272Flank PainFAERS: 4OFFSIDES
US FAERS
273Floppy iris syndromeFAERS: 4US FAERS
274Gestational DiabetesFAERS: 4US FAERS
275Hyperdynamic left ventricleFAERS: 4US FAERS
276Impaired driving abilityFAERS: 4US FAERS
277Injection site painFAERS: 4US FAERS
278Insulin ResistanceFAERS: 4

View details

CTD
OFFSIDES
US FAERS
279Lipase increasedFAERS: 4US FAERS
280Low birth weight babyFAERS: 4US FAERS
281MELAS SyndromeFAERS: 4US FAERS
282MicrocephalyFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
283MicrophthalmosFAERS: 4US FAERS
284Muscle RigidityFAERS: 4US FAERS
285Muscle tightnessFAERS: 4US FAERS
286NasopharyngitisFAERS: 4SIDER
US FAERS
287Nutritional condition abnormalFAERS: 4US FAERS
288Ocular icterusFAERS: 4US FAERS
289OnychoclasisFAERS: 4US FAERS
290Peripheral arterial occlusive diseaseFAERS: 4US FAERS
291PolydipsiaFAERS: 4US FAERS
292Product residue presentFAERS: 4
Canada Vigilance: 12
Canada Vigilance
US FAERS
293PyelonephritisFAERS: 4US FAERS
294RestlessnessFAERS: 4US FAERS
295Slow speechFAERS: 4US FAERS
296Squamous cell carcinomaFAERS: 4US FAERS
297Supraventricular tachycardiaFAERS: 4US FAERS
298Vitamin B12 absorption test abnormalFAERS: 4US FAERS
299Vulvovaginal burning sensationFAERS: 4US FAERS
300Vulvovaginal discomfortFAERS: 4US FAERS
301Accidental exposure to product by childFAERS: 3US FAERS
302AcneFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
303Alcohol interactionFAERS: 3US FAERS
304Amylase increasedFAERS: 3US FAERS
305Anaphylactic shockFAERS: 3US FAERS
306Anorexia NervosaFAERS: 3US FAERS
307ArthropathyFAERS: 3OFFSIDES
US FAERS
308AscitesFAERS: 3US FAERS
309AsthmaFAERS: 3OFFSIDES
US FAERS
310Back disorderFAERS: 3OFFSIDES
US FAERS
311Blood bicarbonate abnormalFAERS: 3US FAERS
312Blood triglycerides increasedFAERS: 3OFFSIDES
US FAERS
313BronchopneumoniaFAERS: 3US FAERS
314Carpal Tunnel SyndromeFAERS: 3US FAERS
315CellulitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
316Cluster HeadacheFAERS: 3US FAERS
317Cold sweatFAERS: 3US FAERS
318Contraindicated drug administeredFAERS: 3US FAERS
319CystFAERS: 3US FAERS
320DiverticulitisFAERS: 3US FAERS
321Drug effective for unapproved indicationFAERS: 3US FAERS
322Drug screen false positiveFAERS: 3US FAERS
323Drug toxicityFAERS: 3US FAERS
324DyscheziaFAERS: 3US FAERS
325DysuriaFAERS: 3OFFSIDES
US FAERS
326Electrolyte imbalanceFAERS: 3US FAERS
327Emotional distressFAERS: 3SIDER
US FAERS
328Extra dose administeredFAERS: 3US FAERS
329False positive investigation resultFAERS: 3US FAERS
330Feeling of body temperature changeFAERS: 3US FAERS
331Food PoisoningFAERS: 3US FAERS
332Foreign body aspirationFAERS: 3US FAERS
333GangreneFAERS: 3US FAERS
334General physical condition abnormalFAERS: 3US FAERS
335HepatosplenomegalyFAERS: 3US FAERS
336HoloprosencephalyFAERS: 3US FAERS
337HungerFAERS: 3US FAERS
338HypersomniaFAERS: 3US FAERS
339HypophagiaFAERS: 3US FAERS
340HypothyroidismFAERS: 3US FAERS
341Impaired gastric emptyingFAERS: 3US FAERS
342Incorrect product storageFAERS: 3US FAERS
343InflammationFAERS: 3US FAERS
344Insulin C-peptide decreasedFAERS: 3US FAERS
345Intestinal ObstructionFAERS: 3US FAERS
346KetosisFAERS: 3US FAERS
347MalnutritionFAERS: 3SIDER
US FAERS
348Mental impairmentFAERS: 3US FAERS
349MonoplegiaFAERS: 3US FAERS
350OverweightFAERS: 3OFFSIDES
US FAERS
351PapuleFAERS: 3US FAERS
352Precancerous skin lesionFAERS: 3US FAERS
353Product contamination physicalFAERS: 3US FAERS
354Product use complaintFAERS: 3US FAERS
355PsoriasisFAERS: 3US FAERS
356RalesFAERS: 3US FAERS
357Rash erythematousFAERS: 3US FAERS
358Renal cystFAERS: 3US FAERS
359Renal tubular acidosisFAERS: 3US FAERS
360SinusitisFAERS: 3OFFSIDES
US FAERS
361TalipesFAERS: 3US FAERS
362Therapeutic response unexpectedFAERS: 3US FAERS
363VasculitisFAERS: 3US FAERS
364Ventricular arrhythmiaFAERS: 3US FAERS
365Wrong drug administeredFAERS: 3US FAERS
366prostatitisFAERS: 3US FAERS
367AbasiaFAERS: 2US FAERS
368AgeusiaFAERS: 2OFFSIDES
US FAERS
369Alanine aminotransferase abnormalFAERS: 2US FAERS
370Alcohol abuseFAERS: 2US FAERS
371Amino acid level increasedFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
372AnosmiaFAERS: 2OFFSIDES
US FAERS
373AphoniaFAERS: 2US FAERS
374Aspartate aminotransferase abnormalFAERS: 2US FAERS
375AsterixisFAERS: 2US FAERS
376BedriddenFAERS: 2US FAERS
377Blood cholesterol increasedFAERS: 2US FAERS
378Blood creatine phosphokinase increasedFAERS: 2OFFSIDES
US FAERS
379Blood electrolytes abnormalFAERS: 2US FAERS
380Blood folate decreasedFAERS: 2US FAERS
381Blood glucagon increasedFAERS: 2US FAERS
382Blood homocysteine increasedFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
383Blood insulin decreasedFAERS: 2US FAERS
384Blood lactic acidFAERS: 2US FAERS
385Blood pH increasedFAERS: 2US FAERS
386Blood pressure immeasurableFAERS: 2US FAERS
387Blood sodium increasedFAERS: 2US FAERS
388Blood urine presentFAERS: 2US FAERS
389Bone painFAERS: 2US FAERS
390Bowel movement irregularityFAERS: 2US FAERS
391Brain DeathFAERS: 2US FAERS
392CardiomegalyFAERS: 230290168CTD
US FAERS
393CataractFAERS: 230958922CTD
US FAERS
394Cerebral InfarctionFAERS: 2US FAERS
395Chronic gastritisFAERS: 2US FAERS
396ClinodactylyFAERS: 2US FAERS
397Clostridium difficile infectionFAERS: 2US FAERS
398Conjunctival pallorFAERS: 2US FAERS
399CraniosynostosisFAERS: 2US FAERS
400Culture urine positiveFAERS: 2US FAERS
401Depressed moodFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
402Diabetic RetinopathyFAERS: 2OFFSIDES
US FAERS
403Drug effect incompleteFAERS: 2US FAERS
404Drug screen positiveFAERS: 2US FAERS
405DysplasiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
406EczemaFAERS: 2US FAERS
407Ejection Fraction DecreasedFAERS: 2US FAERS
408Ejection fraction abnormalFAERS: 2OFFSIDES
US FAERS
409Emotional disorderFAERS: 2US FAERS
410EnterocolitisFAERS: 2OFFSIDES
US FAERS
411Epigastric discomfortFAERS: 2SIDER
US FAERS
412ErysipelasFAERS: 2US FAERS
413Feeling jitteryFAERS: 2US FAERS
414Foreign body in respiratory tractFAERS: 2US FAERS
415Gastric DilatationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
416Gastrointestinal stoma complicationFAERS: 2US FAERS
417GoutFAERS: 2US FAERS
418Haptoglobin DecreasedFAERS: 2US FAERS
419Heart sounds abnormalFAERS: 2US FAERS
420HepatomegalyFAERS: 223457588CTD
US FAERS
421HydrocephalusFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
422HyperphagiaFAERS: 2US FAERS
423HypertrichosisFAERS: 2US FAERS
424HypokinesiaFAERS: 2US FAERS
425HypoventilationFAERS: 2US FAERS
426IncoherentFAERS: 2US FAERS
427Initial insomniaFAERS: 2US FAERS
428Intentional self-injuryFAERS: 2US FAERS
429Joint stiffnessFAERS: 2US FAERS
430Klebsiella test positiveFAERS: 2US FAERS
431Large intestine perforationFAERS: 2US FAERS
432LymphadenopathyFAERS: 2US FAERS
433LymphomaFAERS: 2US FAERS
434MYELODYSPLASTIC SYNDROMEFAERS: 2US FAERS
435Malignant neoplasm progressionFAERS: 2OFFSIDES
US FAERS
436Metabolic alkalosisFAERS: 2US FAERS
437Middle insomniaFAERS: 2US FAERS
438Musculoskeletal stiffnessFAERS: 2US FAERS
439MyoclonusFAERS: 214984458
19432690
CTD
US FAERS
440Nerve injuryFAERS: 2US FAERS
441NervousnessFAERS: 2US FAERS
442Night sweatsFAERS: 2US FAERS
443ObesityFAERS: 220823565CTD
US FAERS
444OsteomyelitisFAERS: 2US FAERS
445Palpable purpuraFAERS: 2US FAERS
446Pancreatic carcinomaFAERS: 2US FAERS
447PeriarthritisFAERS: 2US FAERS
448Peripheral venous diseaseFAERS: 2US FAERS
449Prescription drug used without a prescriptionFAERS: 2US FAERS
450Product availability issueFAERS: 2US FAERS
451Product coating issueFAERS: 2US FAERS
452Product dosage form issueFAERS: 2US FAERS
453Product dose omissionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
454Product formulation issueFAERS: 2US FAERS
455Product storage errorFAERS: 2US FAERS
456PurpuraFAERS: 2US FAERS
457Reaction to drug excipientsFAERS: 2US FAERS
458Reaction to excipientFAERS: 2US FAERS
459Rectal tenesmusFAERS: 2US FAERS
460Renal malpositionFAERS: 2US FAERS
461Renal painFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
462Similar reaction on previous exposure to drugFAERS: 2US FAERS
463SplenomegalyFAERS: 2US FAERS
464StomatitisFAERS: 2US FAERS
465Suspected counterfeit productFAERS: 2US FAERS
466Therapeutic product effect decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
467Troponin increasedFAERS: 2US FAERS
468Urinary IncontinenceFAERS: 2US FAERS
469Urinary tract obstructionFAERS: 2US FAERS
470Urine ketone body presentFAERS: 2US FAERS
471Vitello-intestinal duct remnantFAERS: 2US FAERS
472WheezingFAERS: 2US FAERS
473White blood cell count decreasedFAERS: 2US FAERS
474insulinomaFAERS: 2US FAERS
475APACHE II score increasedFAERS: 1US FAERS
476APACHE II scoreFAERS: 1US FAERS
477Abdominal InfectionFAERS: 1US FAERS
478Abdominal massFAERS: 1US FAERS
479AbscessFAERS: 1US FAERS
480Acute prerenal failureFAERS: 1SIDER
US FAERS
481Acute respiratory failureFAERS: 1US FAERS
482AdenocarcinomaFAERS: 1OFFSIDES
US FAERS
483AdrenalectomyFAERS: 1US FAERS
484Amphetamines positiveFAERS: 1US FAERS
485Amyotrophic Lateral SclerosisFAERS: 1US FAERS
486Anaphylactoid ReactionFAERS: 1US FAERS
487AnencephalyFAERS: 1US FAERS
488Animal biteFAERS: 1US FAERS
489Ankle FractureFAERS: 1US FAERS
490AnorexiaFAERS: 115752411CTD
OFFSIDES
SIDER
US FAERS
491Anoxic EncephalopathyFAERS: 1US FAERS
492Anterior chamber cleavage syndromeFAERS: 1US FAERS
493Aortic Valve StenosisFAERS: 1US FAERS
494AphagiaFAERS: 1US FAERS
495AphasiaFAERS: 1US FAERS
496Aphthous StomatitisFAERS: 1US FAERS
497AsphyxiaFAERS: 1US FAERS
498Atrioventricular BlockFAERS: 1US FAERS
499AuraFAERS: 1US FAERS
500Autoimmune neutropeniaFAERS: 1US FAERS
501Bacterial VaginosisFAERS: 1US FAERS
502Benign Prostatic HyperplasiaFAERS: 1US FAERS
503Benign neoplasm of spinal cordFAERS: 1US FAERS
504Bladder cancer recurrentFAERS: 1US FAERS
505Blood alkaline phosphatase increasedFAERS: 1US FAERS
506Blood bicarbonateFAERS: 1US FAERS
507Blood cholesterol abnormalFAERS: 1OFFSIDES
US FAERS
508Blood creatinine abnormalFAERS: 1US FAERS
509Blood creatinine decreasedFAERS: 1US FAERS
510Blood ethanol increasedFAERS: 1US FAERS
511Blood follicle stimulating hormone decreasedFAERS: 1US FAERS
512Blood follicle stimulating hormone increasedFAERS: 1US FAERS
513Blood iron abnormalFAERS: 1US FAERS
514Blood ketone bodyFAERS: 1US FAERS
515Blood parathyroid hormone increasedFAERS: 1US FAERS
516Blood potassium abnormalFAERS: 1US FAERS
517Breast tendernessFAERS: 1US FAERS
518Bronchial ObstructionFAERS: 1US FAERS
519Bronchial wall thickeningFAERS: 1US FAERS
520Capillary Leak SyndromeFAERS: 1US FAERS
521Carbon dioxide decreasedFAERS: 1US FAERS
522Carcinoma in situ of skinFAERS: 1US FAERS
523Cardiac FlutterFAERS: 1US FAERS
524Cardiac TamponadeFAERS: 1US FAERS
525Central Nervous System InfectionFAERS: 1US FAERS
526Central nervous system lesionFAERS: 1US FAERS
527Cerebral atrophyFAERS: 1US FAERS
528Cerebral calcificationFAERS: 1US FAERS
529Choking sensationFAERS: 1OFFSIDES
US FAERS
530Cleft PalateFAERS: 1US FAERS
531Coagulation factor VII level decreasedFAERS: 1US FAERS
532Coating in mouthFAERS: 1US FAERS
533Coma scaleFAERS: 1US FAERS
534Concomitant disease aggravatedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
535Consciousness fluctuatingFAERS: 1US FAERS
536Contraindicated product prescribedFAERS: 1US FAERS
537Conversion disorderFAERS: 1US FAERS
538Coronary Artery DiseaseFAERS: 1US FAERS
539CryingFAERS: 1US FAERS
540Dacryostenosis congenitalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
541DemyelinationFAERS: 1US FAERS
542Dengue FeverFAERS: 1US FAERS
543Dental cariesFAERS: 1US FAERS
544Dental gangreneFAERS: 1US FAERS
545Developmental Coordination DisorderFAERS: 1US FAERS
546Device battery issueFAERS: 1US FAERS
547Device occlusionFAERS: 1OFFSIDES
US FAERS
548Diastolic dysfunctionFAERS: 1US FAERS
549DisabilityFAERS: 1US FAERS
550Disease recurrenceFAERS: 1US FAERS
551Documented hypersensitivity to administered productFAERS: 1US FAERS
552Drug clearance decreasedFAERS: 1US FAERS
553Drug effect variableFAERS: 1US FAERS
554Drug level changedFAERS: 1US FAERS
555Drug level decreasedFAERS: 1US FAERS
556Drug resistanceFAERS: 1US FAERS
557Drug withdrawal syndromeFAERS: 1US FAERS
558Drug-disease interactionFAERS: 1US FAERS
559Dumping SyndromeFAERS: 1US FAERS
560Duodenal UlcerFAERS: 1OFFSIDES
US FAERS
561DysphoniaFAERS: 1US FAERS
562DystoniaFAERS: 1US FAERS
563Ear discomfortFAERS: 1US FAERS
564EcchymosisFAERS: 1US FAERS
565Economic problemFAERS: 1OFFSIDES
US FAERS
566Electrocardiogram T wave peakedFAERS: 1US FAERS
567EmbolismFAERS: 1US FAERS
568Enzyme level increasedFAERS: 1US FAERS
569EosinophiliaFAERS: 1US FAERS
570Erectile dysfunctionFAERS: 1OFFSIDES
US FAERS
571EscharFAERS: 1US FAERS
572Essential TremorFAERS: 1US FAERS
573Expired product administeredFAERS: 1US FAERS
574Exposure to toxic agentFAERS: 1US FAERS
575Exposure via body fluidFAERS: 1US FAERS
576Exposure via fatherFAERS: 1US FAERS
577Eye irritationFAERS: 1US FAERS
578Eyelash injuryFAERS: 1US FAERS
579Fine motor delayFAERS: 1US FAERS
580Fixed drug eruptionFAERS: 1US FAERS
581Foaming at mouthFAERS: 1US FAERS
582Food AllergyFAERS: 1US FAERS
583Foreign body traumaFAERS: 1US FAERS
584FormicationFAERS: 1US FAERS
585Full blood count abnormalFAERS: 1US FAERS
586Full blood count increasedFAERS: 1US FAERS
587Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
588Gastric BypassFAERS: 1US FAERS
589GastroduodenitisFAERS: 1US FAERS
590Gastrointestinal hypermotilityFAERS: 1US FAERS
591Gastrointestinal wall thickeningFAERS: 1US FAERS
592GastrostomyFAERS: 1US FAERS
593Gaze palsyFAERS: 1US FAERS
594Gene MutationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
595Genital abscessFAERS: 1US FAERS
596GlossoptosisFAERS: 1US FAERS
597Gluten sensitivityFAERS: 1US FAERS
598GranulocytosisFAERS: 1US FAERS
599Growth retardationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
600Guillain-Barre SyndromeFAERS: 1US FAERS
601Head BangingFAERS: 1US FAERS
602Head circumference abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
603Head discomfortFAERS: 1US FAERS
604HemiparesisFAERS: 1US FAERS
605HemiplegiaFAERS: 1US FAERS
606Hepatic InfectionFAERS: 1US FAERS
607Hepatic congestionFAERS: 1US FAERS
608Histiocytosis haematophagicFAERS: 1US FAERS
609HydronephrosisFAERS: 1OFFSIDES
US FAERS
610HyperchlorhydriaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
611Hypermobility syndromeFAERS: 1US FAERS
612Hypertrophic CardiomyopathyFAERS: 1US FAERS
613Hypoglossal Nerve DisorderFAERS: 1US FAERS
614HypoperfusionFAERS: 1US FAERS
615Hypoplastic Left Heart SyndromeFAERS: 1US FAERS
616Hyporesponsive to stimuliFAERS: 1US FAERS
617Inappropriate schedule of product administrationFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
618Incision site complicationFAERS: 1US FAERS
619IncontinenceFAERS: 1US FAERS
620Incorrect route of drug administrationFAERS: 1US FAERS
621Incorrect route of product administrationFAERS: 1US FAERS
622Infantile vomitingFAERS: 1US FAERS
623Infected biteFAERS: 1US FAERS
624Injection Site ReactionFAERS: 1US FAERS
625Insurance issueFAERS: 1US FAERS
626Intercepted drug dispensing errorFAERS: 1US FAERS
627Intervertebral Disc DegenerationFAERS: 1OFFSIDES
US FAERS
628LabyrinthitisFAERS: 1US FAERS
629LacerationFAERS: 1US FAERS
630LaryngitisFAERS: 1US FAERS
631LazinessFAERS: 1US FAERS
632Leukocytoclastic vasculitisFAERS: 1US FAERS
633LeukopeniaFAERS: 1US FAERS
634Ligament ruptureFAERS: 1US FAERS
635Limb injuryFAERS: 1US FAERS
636Lip exfoliationFAERS: 1US FAERS
637Loss of personal independence in daily activitiesFAERS: 1US FAERS
638Low set earsFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
639Lower respiratory tract infectionFAERS: 1US FAERS
640Lupus-like syndromeFAERS: 1US FAERS
641MaculeFAERS: 1US FAERS
642MalabsorptionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
643Mantle cell lymphomaFAERS: 1US FAERS
644Maternal exposure before pregnancyFAERS: 1US FAERS
645Maternal exposure during deliveryFAERS: 1US FAERS
646Medication residueFAERS: 1US FAERS
647MeningomyeloceleFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
648MicroalbuminuriaFAERS: 1US FAERS
649MicrogeniaFAERS: 1US FAERS
650MicrostomiaFAERS: 1US FAERS
651Mixed liver injuryFAERS: 1US FAERS
652Motion SicknessFAERS: 1US FAERS
653Mouth swellingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
654Mucosal pigmentationFAERS: 1US FAERS
655Multi-organ disorderFAERS: 1OFFSIDES
US FAERS
656Multiple allergiesFAERS: 1US FAERS
657Musculoskeletal discomfortFAERS: 1SIDER
US FAERS
658Myasthenia GravisFAERS: 1US FAERS
659Myocardial ruptureFAERS: 1US FAERS
660Myoglobin blood increasedFAERS: 1US FAERS
661NecrosisFAERS: 1US FAERS
662Needle issueFAERS: 1US FAERS
663Nephrotic SyndromeFAERS: 1US FAERS
664NeuralgiaFAERS: 1US FAERS
665NeuritisFAERS: 1US FAERS
666Neurological examination abnormalFAERS: 1US FAERS
667Neutrophil count decreasedFAERS: 1US FAERS
668Neutrophil hypersegmented morphology presentFAERS: 1US FAERS
669No reaction on previous exposure to drugFAERS: 1US FAERS
670NocturiaFAERS: 1US FAERS
671NoduleFAERS: 1US FAERS
672Nonspecific reactionFAERS: 1US FAERS
673ObstructionFAERS: 1US FAERS
674Ocular discomfortFAERS: 1US FAERS
675OligohydramniosFAERS: 1US FAERS
676OnycholysisFAERS: 1US FAERS
677Optic Nerve HypoplasiaFAERS: 1US FAERS
678Oral painFAERS: 1US FAERS
679PancreatectomyFAERS: 1US FAERS
680Pancreatic NeoplasmFAERS: 1OFFSIDES
US FAERS
681Pancreatic enzymes increasedFAERS: 1US FAERS
682PancreaticoduodenectomyFAERS: 1US FAERS
683Paradoxical drug reactionFAERS: 1US FAERS
684Patent ductus arteriosusFAERS: 1US FAERS
685PemphigusFAERS: 1US FAERS
686Performance status decreasedFAERS: 1OFFSIDES
US FAERS
687Perirectal abscessFAERS: 1US FAERS
688PeritonitisFAERS: 1US FAERS
689PhotophobiaFAERS: 1US FAERS
690Physical disabilityFAERS: 1US FAERS
691Pneumatosis intestinalisFAERS: 1US FAERS
692Poor quality sleepFAERS: 1US FAERS
693Portal HypertensionFAERS: 1US FAERS
694Post procedural complicationFAERS: 1US FAERS
695Post procedural infectionFAERS: 1US FAERS
696Post procedural sepsisFAERS: 1US FAERS
697Prader-Willi SyndromeFAERS: 1US FAERS
698Pre-EclampsiaFAERS: 115910403CTD
US FAERS
699Pregnancy test negativeFAERS: 1US FAERS
700Pregnancy test positiveFAERS: 1US FAERS
701Procedural hypotensionFAERS: 1US FAERS
702Product comminglingFAERS: 1US FAERS
703Product label confusionFAERS: 1US FAERS
704Product packaging issueFAERS: 1US FAERS
705Product packaging quantity issueFAERS: 1US FAERS
706Product physical consistency issueFAERS: 1US FAERS
707Product shape issueFAERS: 1US FAERS
708Product supply issueFAERS: 1US FAERS
709Protein S decreasedFAERS: 1US FAERS
710Protein urine presentFAERS: 1US FAERS
711Prothrombin level decreasedFAERS: 1US FAERS
712Pulmonary FibrosisFAERS: 13091170CTD
US FAERS
713Pulmonary arterial hypertensionFAERS: 1US FAERS
714Pulmonary congestionFAERS: 1US FAERS
715Pulmonary interstitial emphysema syndromeFAERS: 1US FAERS
716PurgingFAERS: 1US FAERS
717PurulenceFAERS: 1US FAERS
718Pustular psoriasisFAERS: 1US FAERS
719QuadriplegiaFAERS: 1US FAERS
720Quality of life decreasedFAERS: 1US FAERS
721Rectal fissureFAERS: 1US FAERS
722Reflux gastritisFAERS: 1US FAERS
723RegurgitationFAERS: 1US FAERS
724Renal Cell CarcinomaFAERS: 1US FAERS
725Renal massFAERS: 1US FAERS
726Renal tubular disorderFAERS: 1US FAERS
727Respiratory fatigueFAERS: 1US FAERS
728Restless Legs SyndromeFAERS: 1US FAERS
729Reticulocyte count abnormalFAERS: 1US FAERS
730Reticulocyte count increasedFAERS: 1US FAERS
731ReticulocytosisFAERS: 1US FAERS
732Retinal Vein OcclusionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
733RosaceaFAERS: 1US FAERS
734Rotator cuff syndromeFAERS: 1US FAERS
735Ruptured ectopic pregnancyFAERS: 1US FAERS
736Saliva alteredFAERS: 1US FAERS
737SchizophreniaFAERS: 1OFFSIDES
US FAERS
738Secretion dischargeFAERS: 1US FAERS
739Sensory level abnormalFAERS: 1US FAERS
740Serotonin SyndromeFAERS: 1US FAERS
741Sinus bradycardiaFAERS: 1US FAERS
742Sinus polypFAERS: 1US FAERS
743Skin lacerationFAERS: 1US FAERS
744Skin reactionFAERS: 1US FAERS
745Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
746SnoringFAERS: 1US FAERS
747Spina BifidaFAERS: 1US FAERS
748Spinal column stenosisFAERS: 1OFFSIDES
US FAERS
749Spinal fusion surgeryFAERS: 1US FAERS
750Status EpilepticusFAERS: 1US FAERS
751SteatohepatitisFAERS: 1US FAERS
752Stool analysis abnormalFAERS: 1US FAERS
753StrabismusFAERS: 1US FAERS
754SunburnFAERS: 1US FAERS
755Swelling of eyelidFAERS: 1US FAERS
756SyndactylyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
757Tablet issueFAERS: 1US FAERS
758Thyroid NeoplasmFAERS: 1US FAERS
759Tinea PedisFAERS: 1US FAERS
760Tongue discomfortFAERS: 1US FAERS
761TonsillectomyFAERS: 1US FAERS
762Tooth InfectionFAERS: 1US FAERS
763Transcription medication errorFAERS: 1US FAERS
764Trigeminal NeuralgiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
765TuberculosisFAERS: 1US FAERS
766Umbilical cord cystFAERS: 1US FAERS
767Umbilical malformationFAERS: 1US FAERS
768UnderweightFAERS: 1US FAERS
769Upper respiratory fungal infectionFAERS: 1US FAERS
770Urinary RetentionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
771Urinary bladder polypFAERS: 1US FAERS
772Urine output increasedFAERS: 1OFFSIDES
US FAERS
773Uterine PolypFAERS: 1US FAERS
774Vascular resistance systemic decreasedFAERS: 1US FAERS
775Venous ThrombosisFAERS: 1US FAERS
776Ventricular DysfunctionFAERS: 1US FAERS
777Visceral congestionFAERS: 1US FAERS
778Vulvovaginal mycotic infectionFAERS: 1US FAERS
779White blood cells stoolFAERS: 1US FAERS
780Wound infection staphylococcalFAERS: 1US FAERS
781Wrong technique in drug usage processFAERS: 1US FAERS
782X-linked chromosomal disorderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
783furuncleFAERS: 1US FAERS
784Abdominal bloatingSIDER
785Abdominal distressSIDER
786AbuseOFFSIDES
787Acid refluxOFFSIDES
788Acidosis, Lactic

View details

CTD
789Acquired macroglossiaOFFSIDES
790Acute glomerulonephritisOFFSIDES
791Acute sinusitisOFFSIDES
792Albuminuria30290168CTD
793Alstrom Syndrome18038714CTD
794AlveolitisOFFSIDES
795Amyloidosis15983227CTD
796Anemia, Hemolytic10644400
12610074
CTD
797Anemia, Megaloblastic7388472
12772378
CTD
798AngioplastyOFFSIDES
799Anorectal discomfortOFFSIDES
800Aortic valve sclerosisOFFSIDES
801AppendectomyOFFSIDES
802AppendicitisOFFSIDES
803AspergillosisOFFSIDES
804AtelectasisOFFSIDES
805Atrial FlutterOFFSIDES
806Beta 2 microglobulin increasedOFFSIDES
807Bipolar I disorderOFFSIDES
808Blood GlucoseOFFSIDES
809Blood albumin decreasedOFFSIDES
810Blood cholesterolOFFSIDES
811Blood immunoglobulin EOFFSIDES
812Blood triglyceridesOFFSIDES
813Body TemperatureOFFSIDES
814Brain AbscessOFFSIDES
815Breathing-related sleep disorderOFFSIDES
816Burning Mouth SyndromeOFFSIDES
817Carcinoma22467055CTD
818Cardiovascular Diseases18458139CTD
819Cerebral ArteriosclerosisOFFSIDES
820Cervical dysplasiaOFFSIDES
821Chemical and Drug Induced Liver Injury

View details

CTD
822Chromosome Breakage29117515CTD
823Chronic Fatigue SyndromeOFFSIDES
824CirrhosisOFFSIDES
825Coagulation factor VIII level abnormalOFFSIDES
826Cognition Disorders24802403CTD
827Colonic Neoplasms22467055CTD
828ConfabulationOFFSIDES
829Confusion14984458CTD
830ContractureOFFSIDES
831Cytolytic hepatitisOFFSIDES
832Degeneration of uterine fibroidOFFSIDES
833Dental abscessOFFSIDES
834DermatitisSIDER
835DiabetesOFFSIDES
836Diabetes Mellitus, Experimental19497428
20869956
CTD
837Diabetic Angiopathies16385087CTD
838Diabetic ulcerOFFSIDES
839Diarrhea14604317CTD
OFFSIDES
840DiplopiaOFFSIDES
841DistentionSIDER
842DrowsinessOFFSIDES
SIDER
843Drug Overdose16644670CTD
844Dyskinesia, Drug-Induced14984458CTD
845Dyslipidemias27270450CTD
846Dysthymic DisorderOFFSIDES
847Ear and labyrinth disordersSIDER
848Electrocardiogram ST-T changeOFFSIDES
849Electrocardiogram poor R-wave progressionOFFSIDES
850Embolic strokeOFFSIDES
851EncephalomalaciaOFFSIDES
852Endomyocardial Fibrosis30290168CTD
853Esophageal StenosisOFFSIDES
854Essential HypertensionOFFSIDES
855Facial NeuralgiaOFFSIDES
856Factor VIII inhibitionOFFSIDES
857Fatty Liver25805502
27270450
CTD
OFFSIDES
858Femoral arterial stenosisOFFSIDES
859Food aversionOFFSIDES
860Gait Disorders, Neurologic14984458
19432690
CTD
861Gastrointestinal motility disorderOFFSIDES
862Gastrointestinal ulcerOFFSIDES
863General physical conditionOFFSIDES
864Genital HerpesOFFSIDES
865Hearing aid userOFFSIDES
866Heart Diseases22666520CTD
867HeartburnSIDER
868Hepatitis COFFSIDES
869Hormone level abnormalOFFSIDES
870Hyperandrogenism15356085
17062894
CTD
871Hyperbilirubinemia10644400CTD
872Hypercholesterolemia27551045CTD
873Hyperglycemia

View details

CTD
874Hyperinsulinism8781288
18377884
CTD
875Hyperkalemia15752411CTD
876Hypertriglyceridemia22627169
27551045
CTD
877ImmunosuppressionOFFSIDES
878Impaired insulin secretionOFFSIDES
879InfestationSIDER
880Insulin-requiring type 2 diabetes mellitusOFFSIDES
881Intermittent ClaudicationOFFSIDES
882Intervertebral disc disorderOFFSIDES
883Jaundice, Obstructive11467664CTD
884Joint sprainOFFSIDES
885KetonemiaSIDER
886KetonuriaSIDER
887Kidney Diseases17520852
20431573
CTD
888Kidney FailureOFFSIDES
889LaparoscopyOFFSIDES
890LightheadednessSIDER
891Limb operationOFFSIDES
892Liver Failure, Acute12639207CTD
893Liver diseases10216414CTD
894Lung Neoplasms26524634CTD
895Malignant HypertensionOFFSIDES
896Mallory-Weiss SyndromeOFFSIDES
897Mechanical ventilationOFFSIDES
898Memory Disorders24802403CTD
899Metabolic Diseases18082302CTD
900MetatarsalgiaOFFSIDES
901MonoparesisOFFSIDES
902Multiple MyelomaOFFSIDES
903Multiple SclerosisOFFSIDES
904Muscle WeaknessOFFSIDES
905Muscle necrosisOFFSIDES
906Muscle strainSIDER
907Musculoskeletal chest painOFFSIDES
908Myositis11062950CTD
909Narcotic intoxicationOFFSIDES
910Neoplasm Metastasis26497364CTD
911Neoplasms22246099
28571774
CTD
912Nephrosclerosis27551045
30290168
CTD
913NeuropathySIDER
914NeutropeniaSIDER
915Non-cardiac chest painOFFSIDES
916Occult blood positiveOFFSIDES
917Oedema aggravatedSIDER
918Oral infectionCanada Vigilance: 1Canada Vigilance
919OrchitisOFFSIDES
920PROTHROMBIN TIMEOFFSIDES
921Pancreatic duct obstructionOFFSIDES
922ParanoiaOFFSIDES
923ParotitisOFFSIDES
924PericarditisOFFSIDES
925Peripheral Nervous System Diseases20134380CTD
926Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
927Polycystic Ovary Syndrome

View details

CTD
928Polymyalgia RheumaticaOFFSIDES
929Poor peripheral circulationCanada Vigilance: 1Canada Vigilance
930Prenatal Exposure Delayed Effects23457588CTD
931Prescribed overdoseOFFSIDES
932Product complaintCanada Vigilance: 2Canada Vigilance
933Product quality control issueCanada Vigilance: 1Canada Vigilance
934Prostatic Hyperplasia26492952CTD
935Pulmonary Edema29859833CTD
936Punctate keratitisOFFSIDES
937Reaction gastrointestinalSIDER
938Renal Insufficiency18431417
27551045
CTD
939RhinitisSIDER
940RhonchiOFFSIDES
941Scrotal cystOFFSIDES
942Seizures24802403CTD
943Sinus headacheOFFSIDES
SIDER
944Skin hypertrophyCanada Vigilance: 1Canada Vigilance
945Skin irritationCanada Vigilance: 1Canada Vigilance
946Staphylococcal abscessOFFSIDES
947StridorOFFSIDES
948Subclavian artery thrombosisOFFSIDES
949SynovitisOFFSIDES
950Tardive DyskinesiaOFFSIDES
951Taste DisordersSIDER
952TetanyOFFSIDES
953Therapeutic response changedCanada Vigilance: 2Canada Vigilance
954Therapy regimen changedOFFSIDES
955ThyroidectomyOFFSIDES
956TonsillitisSIDER
957ToothacheSIDER
958Upset stomachSIDER
959Vasculitis, Leukocytoclastic, Cutaneous3091170
16882868
CTD
960Ventricular Dysfunction, Left24842192CTD
961Vision Disorders14604317CTD
962Vitamin B 12 Deficiency

View details

CTD
963Vitamin B12 absorption decreasedSIDER
964Vitreous DetachmentOFFSIDES
965Vulvovaginal pruritusOFFSIDES
966Weight Gain

View details

CTD
OFFSIDES
967Wound DebridementOFFSIDES
968bone marrow fibrosisOFFSIDES
969nervous system disorderSIDER
970synovial sarcomaOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120141

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.